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A B S T R A C T
The incidence of pregnancy complications in women with type 1 Diabetes Mellitus (T1D) is greater than in
healthy pregnant women. This has mostly been attributed to hyperglycemia. However, despite the im-
plementation of stricter guidelines regarding glycemic control, pregnancy complications remain more common
in women with T1D. This may suggest that other etiological factors are involved. We suggest that the immune
response may play a role, since the immune response has to adapt during pregnancy in order to facilitate im-
plantation, placental and fetal development, and aberrant immunological adaptations to pregnancy are involved
in various pregnancy complications. Since T1D is an autoimmune disorder, the question rises whether the im-
mune response of women with T1D is able to adapt properly during pregnancy. Here we review the current proof
and views on the role of aberrant immunological adaptations in pregnancy complications and whether such
aberrant adaptations could be involved in the pregnancy complications of T1D patients.
1. Introduction
Pregnancy in women with type 1 Diabetes Mellitus (T1D) is asso-
ciated with an increased risk of obstetrical and fetal complications like
miscarriage, preeclampsia, macrosomia, congenital malformations and
even perinatal death (Evers et al., 2004). Up to now, these complica-
tions have been attributed mainly to the eﬀects of hyperglycemia (Evers
et al., 2004). Therefore strict guidelines have been imposed for the care
of diabetic women. These guidelines recommend an HbA1c<53
mmol/mol before and during pregnancy in order to create advanta-
geous conditions for implantation and fetal development (American
Diabetes Association, 2002). Although this approach has indeed re-
sulted in an improved pregnancy outcome, the incidence of pregnancy
complications in women with diabetes is still greater than in healthy
women (Murphy et al., 2008). The question therefore arises whether
other etiological factors are involved.
In healthy pregnancies adaptations in immune responses take place
in order to assure successful implantation and placental and fetal de-
velopment (Svensson-Arvelund et al., 2014). The importance of these
immunological adaptations is reinforced by the ﬁndings that many
pregnancy complications are associated with aberrant immune re-
sponses (Raghupathy et al., 2012; Melgert et al., 2012; Saito et al.,
2010; Williams et al., 2009; Tuckerman et al., 2007). Recently we have
shown that immunological adaptations to pregnancy are diﬀerent in
women with T1D than in healthy women (Groen et al., 2015a).
Therefore, we hypothesized that aberrant immune responses in diabetic
pregnancy might play a role in the unfavorable pregnancy outcomes of
women with this disease. Here we review the current proof and views
on the role of aberrant immunological adaptations in pregnancy com-
plications and whether such aberrant adaptations could play a role in
the pregnancy complications of T1D patients.
2. Pregnancy and immune responses
Most pregnancies result in the successful delivery of a healthy child.
Major maternal changes in hemodynamics, cardiology and immunology
occur during pregnancy, facilitating optimal conditions for develop-
ment of the fetus, and preparing for delivery and lactation (Svensson-
Arvelund et al., 2014; Duvekot and Peeters, 1994). Aberrant adaptions,
especially in immune responses, may result in pregnancy complications
like infertility, miscarriage, preeclampsia, prematurity and even peri-
natal or maternal death (Raghupathy et al., 2012; Melgert et al., 2012;
Saito et al., 2010; Williams et al., 2009; Tuckerman et al., 2007). It has
been suggested that the placenta plays a prominent regulating role in
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the immunological adaptations during pregnancy (Svensson-Arvelund
et al., 2014). In humans, placentation is characterized as hemochorial,
indicating that maternal blood is in direct contact with the fetal chorion
(Pijnenborg et al., 2011). This poses major challenges to the immune
system, since fetal tissue is semi-allogeneic (Svensson-Arvelund et al.,
2014). The fact that this semi-allogeneic fetal tissue is tolerated during
pregnancy is accomplished both by fetal adaptations and by adaptations
of the maternal immune response (Veenstra van Nieuwenhoven et al.,
2003a). Here we will focus on these latter adaptations.
2.1. Local immune response during pregnancy
Changes in the local immune response in the uterus (at the im-
plantation site) are necessary for optimal implantation, decidualization,
placentation and fetal tolerance (Veenstra van Nieuwenhoven et al.,
2003a). The numbers of immune cells in the non-pregnant en-
dometrium ﬂuctuate during the menstrual cycle, which may reﬂect
hormonal changes (King et al., 1989; Moﬀett-King, 2002). It is thought
that these immune cells, consisting mainly of uterine natural killer
(uNK) cells, macrophages, regulator T-cells (Treg), and uterine den-
dritic cells (DCs) are important for the cyclic menstrual bleeding (King
et al., 1989; Moﬀett-King, 2002). In early pregnancy, the numbers of
uterine immune cells increase at the endometrial implantation site,
which is now called the decidua (King et al., 1989; Moﬀett-King, 2002).
uNK cells are the most abundant immune cells in the decidua during
early pregnancy and they are involved in angiogenesis, spiral artery
remodeling, and invasion of trophoblast cells into the decidua (King
et al., 1989; Moﬀett-King, 2002). These uNK cells may also play a role
in regulating the inﬂammatory response at the fetomaternal interface
by, for instance, suppressing the pro-inﬂammatory T-helper 17 (Th17)
cells (Fu et al., 2013). Another important cell population in the decidua
and uterine wall are the macrophages (Faas et al., 2014). These cells are
also thought to have a signiﬁcant function in regulation of trophoblast
invasion and spiral artery remodeling (Faas et al., 2014). It has been
suggested that Treg play an important role in controlling the function of
immune cells in the decidua in early pregnancy, since the number of
Treg in the decidua increase during early pregnancy and decrease at the
end of gestation (Guerin et al., 2009).
How these local immune adaptions are induced is not exactly
known. Various mechanisms may be involved. There is evidence that
both hormonal changes and semen may play an important role in the
local immunological adaptations (Booker et al., 1994; Remes Lenicov
et al., 2012). The increased production of progesterone during the se-
cretory phase of the menstrual cycle induces the inﬂux of leukocytes
(Booker et al., 1994). Recent studies have shown that uterine DCs be-
come activated after exposure to semen and fetal antigens, thereby
attracting other immune cells, like uNK cells, into the uterus (Remes
Lenicov et al., 2012). Furthermore, semen may also cause an accumu-
lation of Treg in the uterus (Guerin et al., 2011). Finally, trophoblast
cells are suggested to be involved in the development of fetomaternal
tolerance. It has, for instance, been shown that ﬁrst-trimester tropho-
blasts are able to recruit uNK cells into the decidua by the CXCL12/
CSCR4 axis (Tao et al., 2015).
2.2. Peripheral immune response during pregnancy
Also peripheral immune responses change during pregnancy.
Clinically, this is obvious from the observations that symptoms of sev-
eral autoimmune diseases can exacerbate during pregnancy (e.g. sys-
temic lupus erythematosus), while symptoms of other autoimmune
diseases (e.g. rheumatoid arthritis) may decrease (Piccinni et al., 2016).
It has long been known that the number of circulating white blood
cells is increased during pregnancy (Siegel and Gleicher, 1981), which
is indicative of an inﬂammatory response. Indeed, monocytes and
granulocytes show upregulation of activation markers, produce in-
creased amounts of oxygen-free radicals, and show diﬀerent production
of cytokines (Sacks et al., 1998; Veenstra van Nieuwenhoven et al.,
2003b). Monocyte maturation has also been observed (Melgert et al.,
2012; Groen et al., 2015a), which also suggests a proinﬂammatory state
during pregnancy.
Moreover, it has been shown that the speciﬁc immune response
shifts away from a T-helper 1 (Th1) and Th17 type immune response
towards a Th2 type response (Saito et al., 2010). It has been assumed
that Treg supports this shift by inhibiting the proliferation and cytokine
production of Th1 and Th17 cells (Saito et al., 2010). NK cell numbers,
as well as the production of IFN-γ by these cells, are decreased
(Borzychowski et al., 2005), suggesting that there is also a shift from a
Th1 towards a Th2 type immune response in NK cells. The mechanisms
by which all these peripheral immune changes are induced are not
completely understood, but have been suggested to be initiated by the
presence of the placenta and its production of proinﬂammatory factors
such as hormones, microparticles and cytokines (Svensson-Arvelund
et al., 2014).
3. Immunological disturbances and pregnancy outcome
Aberrations in local immunological adaptations during pregnancy
are associated with adverse pregnancy outcome (Raghupathy et al.,
2012; Melgert et al., 2012; Saito et al., 2010; Williams et al., 2009;
Tuckerman et al., 2007). Pregnancy complications associated with
aberrant implantation and placentation, such as recurrent pregnancy
loss, preeclampsia or intrauterine growth retardation (IUGR), may be
associated with altered numbers and function of uNK cells and mac-
rophages in the decidua (Fig. 1). Indeed, uNK cell numbers were de-
creased in the decidua of women with preeclampsia and IUGR
(Williams et al., 2009), while also in women with preeclampsia in-
creased numbers of decidual M1 macrophages (classically activated
macrophages) were found (Schonkeren et al., 2011). On the other hand,
increased numbers of uNK cells in the decidua have been shown in
recurrent pregnancy loss (Tuckerman et al., 2007). Also in women with
IUGR a shift towards Th1 type cytokines in the decidua was found
(Prins et al., 2012). These data suggest that an optimal number of in-
ﬂammatory cells need to be present in the decidua in order to ensure
normal implantation and placentation.
Aberrant adaptations of the peripheral immune response are also
seen in women with pregnancy complications (Fig. 2). Preeclampsia,
for instance, is associated with systemic inﬂammation, characterized by
phenotypical activation and functional changes of monocytes and
granulocytes (Sacks et al., 1998) as well as changes in monocyte subsets
(Melgert et al., 2012; Groen et al., 2015a). In contrast to the shift to-
wards a Th2 response occurring during normal pregnancy, pre-
eclampsia is associated with a Th1 immune response (Saito et al.,
2010). Also other pregnancy complications are associated with changes
in immune responses. In women with IUGR, as compared to women
with normal pregnancy outcome, an increased total lymphocyte count
was observed, which coincided with an increased percentage of B-, T-,
and helper T-lymphocytes (Bartha and Comino-Delgado, 1999). In
women with recurrent miscarriage, increased NK cell numbers in the
peripheral blood were observed (Hosseini et al., 2014). Also a pre-
dominance of Th1 immunity was often shown in women with IUGR and
preterm birth (Raghupathy et al., 2012; Makhseed et al., 2003). As T1D,
but also other autoimmune diseases like rheumatoid arthritis (Norgaard
et al., 2010) and systemic lupus erythematosus (Cervera et al., 2002), is
associated with increased pregnancy complications, the question arises
whether T1D during pregnancy is also associated with aberrant im-
munological adaptations to pregnancy.
4. Type 1 diabetes and pregnancy
T1D is an autoimmune disease in which the pancreatic beta cells are
destroyed by a cell-mediated autoimmune process (Wallberg and
Cooke, 2013). This autoimmune process is characterized by a Th1/
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Th17 cell-mediated response that involves the innate as well as the
speciﬁc immune response (Wallberg and Cooke, 2013). The pathogen-
esis and etiology of T1D is heterogenic. Both genetic predisposition and
environmental factors such as viral infections are included in the
etiology (Wallberg and Cooke, 2013). Viruses can directly infect beta
cells with subsequent damage, upregulation of MHC-I and release of
antigens and cytokines, aﬀecting the adaptive and innate immune re-
sponse, ultimately resulting in autoimmunity against beta cells
(Wallberg and Cooke, 2013). Viruses can also aﬀect adjacent cells or
cells at other locations, as for instance immune cells (Coppieters and
von Herrath, 2011). Infection of immune cells with viruses carrying
cross reactive epitopes of beta cells may result in molecular mimicry
and therefore also in autoimmunity against beta cells (Coppieters and
von Herrath, 2011). It has recently also been speculated that a ‘leaky
gut’ may be involved. As a consequence of the elevated permeability of
the intestine, macromolecular structures may enter the circulation and
induce, via molecular mimicry, immune responses against epitopes
present on beta cells (Vaarala, 2012). Animal studies in the diabetes
prone BB rat and non-obese diabetic (NOD) (Kikutani and Makino,
1992; Mordes et al., 2004) have shown that many cell types are in-
volved in the process of beta cell destruction, such as (type 1) macro-
phages, NK-cells, B and T lymphocytes (Jun et al., 1999; Gur et al.,
2010; Noorchashm et al., 1997; Bending et al., 2009). Most of these
cells have been shown to be important in immunological pregnancy
adaptations.
Not only is the autoimmune response seen in the pancreas of T1D
patients, also peripheral immune responses have shown to be diﬀerent
in T1D patients as compared to healthy individuals. A recent study
demonstrated that Treg cells are decreased in patients with T1D
(Haseda et al., 2013). Further, it has been shown that the peripheral
immune response in patients with T1D is characterized by an increased
Th1/Th2 ratio, increased Th17 responses, dysfunctional Treg, and in-
creased expression of IFN-γ by NK-cells (Groen et al., 2015a; Haseda
et al., 2013; Honkanen et al., 2010). Interestingly, the T1D induced
immunological changes seem to be the opposite of the changes needed
during pregnancy (Fig. 3).
Fig. 1. Immune responses during spiral artery remodeling.
A: Local immune responses at the implantation site in the non-pregnant endometrium. In the endometrium relatively low numbers of uNK cells and macrophages are
found. Trophoblast cells are absent.
B: Immunological adaptations in the decidua during normal pregnancy. In the decidua increased numbers of uNK cells and macrophages (mainly type 2) can be
found, as well as extravillous trophoblasts. Together, these cells remodel the spiral arteries into large diameter conduit vessels with low resistance, assuring a constant
blood supply to the intervillous space of the placenta.
C: Decidua in pregnancy complications such as preeclampsia. The number of uNK cells is decreased and there is less trophoblast invasion. On the other hand, there is
an increase of type 1 macrophages and an increased production of Th1 cytokines, As a result, there is less remodeling of spiral arteries. This may result in pregnancy
complications like preeclampsia.
Fig. 2. Immunological adaptations to preg-
nancy, preeclampsia and type 1 diabetes.
Immunological adaptations in the peripheral
immune response during normal pregnancy,
preeclampsia and in pregnant women with
type 1 diabetes (T1D P).
It can be observed that many immunological
adaptations in T1D pregnancy are similar to
the aberrant adaptions in preeclampsia.
Arrow up: an increase as compared to healthy
non-pregnant women.
Arrow down: a decrease as compared to
healthy non-pregnant women.
‘=’ no change as compared to healthy non-
pregnant women.
A double arrow indicates a more prominent
increase/decrease.
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T1D is associated with an increased incidence of pregnancy com-
plications (Evers et al., 2004), even when, as outlined in the in-
troduction, glycaemia is strictly controlled. This should not be inter-
preted as a suggestion that glycemic control is not of pivotal importance
for a healthy pregnancy during T1D. The importance of adequate gly-
cemic control has convincingly been demonstrated by preconceptional
improvement of glycemic control or continuous glucose monitoring for
prevention of congenital malformations and macrosomia (Murphy
et al., 2008; Kitzmiller et al., 1991). However, although congenital
malformations and macrosomia can be directly related to hypergly-
cemia, strong evidence for a sole inﬂuence of hyperglycemia on re-
current miscarriage, pre-eclampsia, IUGR and preterm birth is largely
lacking. As described above, these complications are also inﬂuenced by
immunological disturbances during pregnancy. Therefore, in a recent
series of experiments we tested the hypothesis that immunological
adaptations to pregnancy are disturbed in women and rats with T1D.
To this end, we studied peripheral immunological changes during
pregnancy in women with T1D and rats with T1D, i.e. diabetic prone BB
rats (Groen et al., 2015a, 2013). We showed many peripheral dis-
turbances in the immunological adaptations in both pregnant women
and pregnant rats with T1D. The most important diﬀerences were found
in Th cells, NK cells and monocytes. We observed an increased Th1/Th2
ratio in pregnant women with T1D versus healthy control women
(Groen et al., 2015a). NK cells showed an increased cytotoxic potential
in pregnant T1D women (Groen et al., 2015a). Our results were in line
with a study from Burke et al, who also found in T1D pregnancies a shift
towards a Th1 immune response as well as changes in peripheral NK
cells (Burke et al., 2015). Moreover, we observed increased numbers of
intermediate monocytes, which also showed an increased MHC-II ex-
pression (Groen et al., 2015a). In T1D pregnant rats, as compared to
non-diabetic pregnant rats, we found similar results, i.e. an increased
percentage of NK cells and intermediate monocytes and an increased
Th1/Th2 ratio (Groen et al., 2013). Therefore, the immune response in
pregnant individuals with T1D may be interpreted as a Th1 type im-
mune response with a general activation of the innate immune re-
sponse. Immune responses with these characteristics are also observed
in non-diabetic women with pregnancy complications like preeclampsia
(Fig. 2). In future studies, it would be important to directly compare
(local and peripheral) immune responses during T1D pregnancy and
preeclamptic pregnancy, since to the best of our knowledge such studies
have never been performed.
In diabetes prone BB rats, we studied the local immune response in
the placental bed, and also here we observed immunological dis-
turbances. There was an increased number of NK cells and type 1
macrophages in the mesometrial triangle in the uterus (i.e. the pla-
cental bed) of T1D pregnant rats as compared to healthy control rats
(Groen et al., 2015b). This was associated with decreased trophoblast
invasion and suboptimal spiral artery remodeling in the T1D rats
(Groen et al., 2015b). Burke et al. studied NK cells in the decidua ba-
salis of NOD mice (also a model for T1D) and found decreased numbers
of uNK cells early in pregnancy (Burke et al., 2007). Diﬀerences be-
tween our study and the study of Burke may be the timing of pregnancy
(day 18 in our study vs days 6–8 in the Burke study) or the location of
the uNK cells (Mesometrial triangle vs decidua basalis). Further studies
are needed to determine whether similar changes take place in the
placental bed of T1D pregnant women.
The immunological changes observed in T1D women and rats are
similar to the immunological changes observed in women with preg-
nancy complications like recurrent miscarriage, preeclampsia, IUGR
and preterm birth and are in line with our hypothesis that the preg-
nancy complications in T1D women may result from aberrant adaptions
of the maternal immune response to pregnancy. Besides the fact that the
immune response of women with T1D is altered due to the auto-
immunity, women with T1D also suﬀer from chronic vascular in-
ﬂammation, which might also aﬀect placentation and the mother’s
vascular response to inﬂammation or inﬂammatory factors, resulting in
pregnancy complications like preeclampsia (Staﬀ and Redman, 2018).
5. Conclusion
We suggest that the pathophysiology of pregnancy complications in
women with pregestational T1D is multifactorial. In addition to hy-
perglycemia, aberrant adaptations of the immune response during the
course of pregnancy may well be responsible for the increased in-
cidence of speciﬁc pregnancy complications like recurrent miscarriage,
preeclampsia, IUGR and preterm birth. Future research should there-
fore focus on possible interventions in the immune response of (pre)
pregnant T1D women and animals, in order to improve pregnancy
outcome.
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